Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunotherapy with Corynebacterium granulosum P40 in Colon Cancer, Breast Cancer, or Melanoma
NCT00002455Phase 3Unknown
- Sponsor
- Centro Oncológico de Excelencia
- Start
- Apr 1971
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, open-label trial of corynebacterium granulosum p40 in colon cancer, breast cancer and melanoma (2 arms), sponsored by Centro Oncológico de Excelencia. Primary endpoints: Recurrence, Response to study parameters and 1 more. Status: unknown.
02
Drugs
corynebacterium granulosum p40
03
Conditions
colon cancerbreast cancermelanoma
Beyond the preview
Go deeper on NCT00002455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002455.